| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
| filingDate |
2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b0ddaf7ea825f3743ce5100d3576df2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38103a00afd8f8e504ca1df1d2db4211
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9621bfbffe0034dcd2f6f91afa8e8375 |
| publicationDate |
2018-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180006747-A |
| titleOfInvention |
Pharmaceutical composition for enhancing the radiotherapy of cancer |
| abstract |
The present invention relates to a pharmaceutical composition capable of enhancing the radiotherapeutic effect on cancer, and more particularly, to a pharmaceutical composition comprising a histone deacetylation inhibitor (HDAC inhibitor) and a kinase inhibitor as an active ingredient And to a pharmaceutical composition for promoting radiation therapy for cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101941045-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190136977-A |
| priorityDate |
2016-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |